StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
486
This month
39
This week
4
This year
197
Today
4
Yesterday
4
Publishing Date
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 18
3
2022 - 05 - 17
3
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 04 - 25
3
2022 - 04 - 06
3
2022 - 03 - 31
3
2022 - 03 - 30
3
2022 - 03 - 25
6
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 16
3
2022 - 03 - 14
3
2022 - 03 - 08
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2022 - 02 - 28
3
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 12 - 16
3
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
2021 - 09 - 08
3
2021 - 08 - 31
4
2021 - 08 - 25
4
2021 - 08 - 24
3
2021 - 08 - 19
5
2021 - 08 - 06
3
2021 - 08 - 05
6
2021 - 08 - 03
3
2021 - 07 - 16
3
2021 - 07 - 08
3
2021 - 06 - 25
3
2021 - 06 - 04
3
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 05 - 07
3
2021 - 04 - 28
3
2021 - 04 - 13
4
2021 - 04 - 09
3
2021 - 04 - 07
3
2021 - 03 - 30
3
2021 - 03 - 18
5
2021 - 03 - 16
3
Sector
Commercial services
5
Communications
1
Consumer durables
3
Consumer non-durables
1
Distribution services
1
Electronic technology
4
Energy minerals
3
Finance
1
Finance and insurance
3
Health services
9
Health technology
486
Manufacturing
93
N/a
4
Process industries
5
Producer manufacturing
8
Professional, scientific, and technical services
4
Retail trade
1
Technology services
7
Tags
Als
6
America
11
Antibody
8
Application
8
Approval
14
Biocanada
6
Biosimilar
13
Breast cancer
9
Cancer
35
Car-t
7
Covid
17
Covid-19
8
Device
14
Diabetes
9
Diabetic
6
Diagnostic
7
Disease
35
Drug
73
Drug delivery
11
Earnings
10
Ema
6
Europe
11
Eye
10
Fda
16
Fda approval
8
Financial results
13
For
20
Gene therapies
8
Gene therapy
11
Growing
10
Growth
84
Health
6
Immunotherapy
8
Injection
7
Iot
7
Leukemia
9
Liver
17
Macular
6
Market
79
Molecular
6
Myeloid leukemia
6
N/a
409
Novartis
46
Order
6
Patent
8
People
13
Pharm-country
6
Pharma
8
Positive
11
Potential
7
Report
39
Research
40
Respiratory
6
Results
26
T-cell
7
Therapeutics
22
Therapy
47
Treatment
56
Trial
12
Vaccine
9
Entities
3m company
447
Abb ltd
601
Abbott laboratories
678
Abbvie inc.
480
Alphabet inc.
329
Amgen inc.
342
Apollo global management, inc
270
Apple inc.
481
Arcelormittal
257
Arrival
1720
Astrazeneca plc
298
Becton, dickinson and company
400
Bnp paribas
540
Boston scientific corporation
286
Bristol-myers squibb company
353
Cisco systems, inc.
416
Danaher corporation
338
Dow inc.
286
Eli lilly and company
857
Ericsson
715
Extreme networks, inc.
317
First bank
314
Firstenergy corp.
253
Ford motor company
267
General electric company
445
Gilead sciences, inc.
261
Glaxosmithkline plc
407
Honeywell international inc.
726
Hubspot, inc.
997
Intel corporation
403
International business machines corporation
330
Johnson & johnson
2193
Kering
374
Koninklijke philips n.v.
454
Live nation entertainment, inc.
308
Lockheed martin corporation
250
Medtronic plc
583
Microsoft corporation
590
Morgan stanley
2095
Nokia corp
231
Nokia corporation
276
Northrop grumman corporation
251
Novartis ag
486
Novo nordisk a/s
294
Oncocyte corporation
269
Ooma, inc.
235
Oracle corporation
543
Orange
2036
Pfizer, inc.
371
Realogy holdings corp.
236
S&p global inc.
232
Sanofi
1865
Sap se
633
Snowflake inc.
336
Thermo fisher scientific inc
626
Total se
703
Transunion
238
Velodyne lidar, inc.
249
Verizon communications inc.
441
X financial
266
Symbols
A
3
ABBV
66
ABT
37
ADAP
5
ALKS
5
ALPMF
22
ALPMY
22
AMGN
63
ARVL
4
AZN
75
AZNCF
48
BAX
13
BDX
11
BGNE
6
BHC
31
BIIB
16
BLUE
9
BMY
46
BSX
12
CLLS
3
CRY
3
CTIC
3
DX
3
EGOV
3
ENDP
4
GE
3
GILD
6
GLAXF
71
GMAB
13
GNMSF
4
GSK
111
IART
6
IMMP
3
INCY
13
IONS
3
JAZZ
5
JNJ
105
LLY
44
MDT
21
MMM
8
MOR
6
MYL
21
NVO
6
NVS
486
NVSEF
284
PFE
36
PHG
6
QGEN
4
QURE
9
RGNX
5
SNNUF
5
SNY
107
SNYNF
62
SYK
8
TAK
20
TEVJF
50
TMO
16
VCEL
6
VTRS
24
XNCR
5
Exchanges
Amex
3
Lse
56
Nasdaq
409
Nyse
486
Tsx
13
Crawled Date
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
3
2022 - 06 - 17
6
2022 - 06 - 06
3
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 18
3
2022 - 05 - 17
3
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 04 - 25
3
2022 - 04 - 06
3
2022 - 03 - 31
3
2022 - 03 - 30
3
2022 - 03 - 25
6
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 16
3
2022 - 03 - 14
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2022 - 03 - 01
3
2022 - 02 - 28
3
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 12 - 16
3
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
2021 - 09 - 08
3
2021 - 09 - 01
4
2021 - 08 - 25
4
2021 - 08 - 24
3
2021 - 08 - 19
5
2021 - 08 - 06
3
2021 - 08 - 05
6
2021 - 08 - 03
3
2021 - 07 - 16
3
2021 - 07 - 08
3
2021 - 06 - 25
3
2021 - 06 - 04
3
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 05 - 07
3
2021 - 04 - 28
3
2021 - 04 - 13
4
2021 - 04 - 09
3
2021 - 04 - 07
3
2021 - 03 - 30
3
2021 - 03 - 18
5
2021 - 03 - 04
2
Crawled Time
00:00
6
00:20
3
01:00
11
01:08
1
02:00
4
03:00
9
04:00
7
04:20
2
05:00
4
06:00
20
06:03
2
07:00
17
08:00
15
08:23
1
09:00
13
10:00
11
11:00
19
12:00
39
12:15
6
12:20
8
12:30
9
13:00
14
13:14
1
13:15
7
13:20
3
13:30
5
13:35
1
13:58
1
14:00
32
14:15
2
14:20
2
14:30
2
15:00
25
15:15
4
15:20
3
15:30
5
16:00
25
16:01
1
16:20
2
17:00
35
18:00
21
19:00
14
20:00
20
20:20
1
21:00
18
22:00
22
22:01
1
23:00
11
23:09
1
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
1
spacfeed.com
1
www.biospace.com
77
www.globenewswire.com
101
www.prnewswire.com
304
www.voyagertherapeutics.com
1
Sort by:
after hours percent change
|
delayed percent change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Novartis ag
save search
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published:
2022-06-27
(Crawled : 16:00)
- prnewswire.com
AZNCF
|
News
|
$129.21
|
|
Health Technology
|
-1.52%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
2.1%
|
O:
1.86%
H:
1.05%
C:
0.24%
LLY
|
News
S
|
$327.27
0.51%
0.04%
|
|
Health Technology
|
2.47%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$43.7
0.02%
0.05%
|
|
Health Technology
|
0.02%
|
O:
-0.16%
H:
0.61%
C:
0.18%
GLAXF
|
News
|
$21.1
|
|
Health Technology
|
4.22%
|
O:
0.47%
H:
3.73%
C:
3.73%
PFE
|
News
|
$51.88
0.56%
0.04%
|
|
Health Technology
|
2.25%
|
O:
1.46%
H:
1.45%
C:
0.78%
SPPI
|
News
A
|
$0.8667
-1.51%
0.0%
|
|
Health Technology
|
-2.27%
|
O:
0.0%
H:
2.28%
C:
-2.27%
SNYNF
|
News
|
$104.5
|
|
Health Technology
|
4.15%
|
O:
4.15%
H:
0.0%
C:
0.0%
BMY
|
News
|
$79.98
1.29%
0.34%
|
|
Health Technology
|
1.73%
|
O:
0.78%
H:
1.72%
C:
0.95%
SNY
|
News
|
$52.62
-1.5%
-0.41%
|
|
Health Technology
|
0.32%
|
O:
0.53%
H:
0.0%
C:
0.0%
AZN
|
News
|
$66.465
-0.65%
-0.42%
|
|
Health Technology
|
0.02%
|
O:
-0.36%
H:
1.22%
C:
0.38%
immunotherapy
report
therapy
cancer
market
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published:
2022-06-27
(Crawled : 15:20)
- prnewswire.com
CRNX
|
News
A
|
$18.59
-5.2%
0.0%
|
|
Health Technology
|
-5.2%
|
O:
0.66%
H:
1.22%
C:
-5.83%
AZN
|
News
|
$66.465
-0.65%
-0.42%
|
|
Health Technology
|
0.02%
|
O:
-0.36%
H:
1.22%
C:
0.38%
ADAP
|
News
S
|
$1.71
5.56%
3.09%
|
|
Health Technology
|
4.94%
|
O:
1.85%
H:
6.67%
C:
3.03%
AZNCF
|
News
|
$129.21
|
|
Health Technology
|
-1.52%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
2.1%
|
O:
1.86%
H:
1.05%
C:
0.24%
GSK
|
News
|
$43.7
0.02%
0.05%
|
|
Health Technology
|
0.02%
|
O:
-0.16%
H:
0.61%
C:
0.18%
GLAXF
|
News
|
$21.1
|
|
Health Technology
|
4.22%
|
O:
0.47%
H:
3.73%
C:
3.73%
AMGN
|
News
|
$244.89
-0.2%
-0.56%
|
|
Health Technology
|
-0.21%
|
O:
-0.08%
H:
0.45%
C:
-0.13%
treatment
therapy
cancer
market
Valued to be $104.2 Million by 2026, Eye Health Supplements Slated for Robust Growth Worldwide
Published:
2022-06-27
(Crawled : 14:00)
- prnewswire.com
PFE
|
News
|
$51.88
0.56%
0.04%
|
|
Health Technology
|
2.25%
|
O:
1.46%
H:
1.45%
C:
0.78%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
2.1%
|
O:
1.86%
H:
1.05%
C:
0.24%
for
health
eye
growth
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published:
2022-06-27
(Crawled : 12:20)
- prnewswire.com
NVO
|
News
|
$112.89
0.69%
0.0%
|
|
Health Technology
|
0.97%
|
O:
0.78%
H:
0.97%
C:
0.19%
CCXI
|
News
|
$26.01
-0.53%
-4.4%
|
|
Health Technology
|
-6.07%
|
O:
-4.88%
H:
1.04%
C:
-1.25%
AZN
|
News
|
$66.465
-0.65%
-0.42%
|
|
Health Technology
|
0.02%
|
O:
-0.36%
H:
1.22%
C:
0.38%
AZNCF
|
News
|
$129.21
|
|
Health Technology
|
-1.52%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
2.1%
|
O:
1.86%
H:
1.05%
C:
0.24%
PFE
|
News
|
$51.88
0.56%
0.04%
|
|
Health Technology
|
2.25%
|
O:
1.46%
H:
1.45%
C:
0.78%
JNJ
|
News
|
$182.12
-0.09%
0.1%
|
|
Health Technology
|
1.04%
|
O:
0.78%
H:
0.94%
C:
0.26%
disease
for
therapy
growth
Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published:
2022-06-24
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
News
|
$16.205
|
|
Manufacturing
|
0.19%
|
O:
4.33%
H:
0.0%
C:
-2.44%
ALPMF
|
News
|
$15.83
|
|
Health Technology
|
0.48%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ABBV
|
News
|
$153.14
0.53%
0.04%
|
|
Health Technology
|
3.19%
|
O:
1.57%
H:
0.0%
C:
0.0%
BHC
A
|
$8.68
-0.8%
0.35%
|
|
Health Technology
|
19.39%
|
O:
5.78%
H:
13.91%
C:
13.78%
IRWD
|
$11.59
2.57%
0.18%
|
|
Health Technology
|
4.98%
|
O:
0.27%
H:
2.08%
C:
1.99%
TAK
|
News
|
$14.06
1.59%
0.0%
|
|
Health Technology
|
2.4%
|
O:
0.36%
H:
0.0%
C:
0.0%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.53%
|
O:
2.38%
H:
0.0%
C:
0.0%
treatment
market
Psoriasis Treatment Market Players Observe Rising Trend of Personalized Medicines, According to TMR Report
Published:
2022-06-24
(Crawled : 12:00)
- prnewswire.com
AZN
|
News
|
$66.465
-0.65%
-0.42%
|
|
Health Technology
|
4.43%
|
O:
4.41%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$182.12
-0.09%
0.1%
|
|
Health Technology
|
3.0%
|
O:
1.94%
H:
0.0%
C:
0.0%
PFE
|
News
|
$51.88
0.56%
0.04%
|
|
Health Technology
|
5.28%
|
O:
2.96%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$129.21
|
|
Health Technology
|
0.43%
|
O:
0.64%
H:
4.18%
C:
1.33%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.53%
|
O:
2.38%
H:
0.0%
C:
0.0%
LLY
|
News
S
|
$327.27
0.51%
0.04%
|
|
Health Technology
|
5.87%
|
O:
3.32%
H:
0.0%
C:
0.0%
treatment
report
psoriasis
market
Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia
Published:
2022-06-24
(Crawled : 12:00)
- globenewswire.com
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.53%
|
O:
2.38%
H:
0.0%
C:
0.0%
scemblix
treatment
for
chmp
novartis
leukemia
positive
Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published:
2022-06-24
(Crawled : 09:00)
- prnewswire.com
ALPMY
|
News
|
$16.205
|
|
Manufacturing
|
0.19%
|
O:
4.33%
H:
0.0%
C:
-2.44%
SNY
|
News
|
$52.62
-1.5%
-0.41%
|
|
Health Technology
|
3.83%
|
O:
3.49%
H:
0.0%
C:
0.0%
ALPMF
|
News
|
$15.83
|
|
Health Technology
|
0.48%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ABBV
|
News
|
$153.14
0.53%
0.04%
|
|
Health Technology
|
3.19%
|
O:
1.57%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$21.1
|
|
Health Technology
|
5.59%
|
O:
3.19%
H:
2.28%
C:
-1.81%
AMGN
|
News
|
$244.89
-0.2%
-0.56%
|
|
Health Technology
|
1.27%
|
O:
0.92%
H:
0.82%
C:
0.56%
GSK
|
News
|
$43.7
0.02%
0.05%
|
|
Health Technology
|
2.75%
|
O:
1.79%
H:
0.95%
C:
0.92%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.53%
|
O:
2.38%
H:
0.0%
C:
0.0%
GLMD
|
$0.4825
3.63%
|
|
Health Technology
|
5.26%
|
O:
1.21%
H:
0.0%
C:
-3.5%
europe
growth
market
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
Published:
2022-06-23
(Crawled : 01:00)
- globenewswire.com
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.84%
|
O:
0.3%
H:
0.0%
C:
0.0%
research
disease
novartis
Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors
Published:
2022-06-22
(Crawled : 00:00)
- globenewswire.com
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.84%
|
O:
0.3%
H:
0.0%
C:
0.0%
fda
for
novartis
approval
tafinlar
Global Recombinant Vaccines Market to Surpass US$ 1,809.7 Million by 2030 - Coherent Market Insights
Published:
2022-06-22
(Crawled : 18:00)
- prnewswire.com
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
3.19%
|
O:
-1.57%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$182.12
-0.09%
0.1%
|
|
Health Technology
|
7.29%
|
O:
1.36%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.62
-1.5%
-0.41%
|
|
Health Technology
|
5.33%
|
O:
-0.4%
H:
0.0%
C:
0.0%
market
Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing
Published:
2022-06-22
(Crawled : 12:00)
- biospace.com/
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
3.19%
|
O:
-1.57%
H:
0.0%
C:
0.0%
Novartis expands Beacon of Hope through alliances with Historically Black Medical Schools to address systemic health disparities
Published:
2022-06-22
(Crawled : 12:00)
- prnewswire.com
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
3.19%
|
O:
-1.57%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.62
-1.5%
-0.41%
|
|
Health Technology
|
5.33%
|
O:
-0.4%
H:
0.0%
C:
0.0%
beacon
novartis
health
Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
Published:
2022-06-21
(Crawled : 20:00)
- globenewswire.com
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
3.19%
|
O:
-1.57%
H:
0.0%
C:
0.0%
gilenya
patent
for
novartis
review
Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published:
2022-06-21
(Crawled : 03:00)
- prnewswire.com
AZN
|
News
|
$66.465
-0.65%
-0.42%
|
|
Health Technology
|
8.66%
|
O:
2.03%
H:
0.0%
C:
0.0%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.65%
|
O:
1.41%
H:
0.0%
C:
0.0%
research
liver
cancer
market
Global Meningitis Vaccines Market to Surpass US$ 6,669.3 Million by 2030 - Coherent Market Insights
Published:
2022-06-20
(Crawled : 19:00)
- prnewswire.com
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.65%
|
O:
1.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.62
-1.5%
-0.41%
|
|
Health Technology
|
6.8%
|
O:
1.4%
H:
0.0%
C:
0.0%
market
Global Gene Therapy Market Research Report 2022-2031 Featuring Major Players - Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc; Audentes Therapeutics; Voyager Therapeutics
Published:
2022-06-20
(Crawled : 12:00)
- prnewswire.com
SNY
|
News
|
$52.62
-1.5%
-0.41%
|
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$104.5
|
|
Health Technology
|
Email alert
Add to watchlist
QURE
S
|
$18.69
-2.2%
-2.67%
|
|
Health Technology
|
Email alert
Add to watchlist
CLLS
|
$3.23
3.53%
-0.32%
|
|
Health Technology
|
Email alert
Add to watchlist
SRPT
|
$76.29
1.42%
0.0%
|
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
Email alert
Add to watchlist
AGTC
|
$0.735
19.13%
20.42%
|
|
Health Technology
|
Email alert
Add to watchlist
BLUE
A
|
$4.275
-2.84%
-2.27%
|
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
Email alert
Add to watchlist
research
report
novartis
therapeutics
therapy
market
Global Tacrolimus Market to Surpass US$ 9,380.2 Million by 2030 - Coherent Market Insights
Published:
2022-06-17
(Crawled : 19:00)
- prnewswire.com
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
Email alert
Add to watchlist
ALPMF
|
News
|
$15.83
|
|
Health Technology
|
Email alert
Add to watchlist
MYL
|
$15.86
0%
|
|
Health Technology
|
Email alert
Add to watchlist
TFFP
|
$6.0
5.45%
-0.18%
|
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
News
|
$16.205
|
|
Manufacturing
|
Email alert
Add to watchlist
tacrolimus
market
Biologic Therapy Market Information: By Product and Geography - Global Forecast till 2025
Published:
2022-06-17
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
News
|
$129.21
|
|
Health Technology
|
7.16%
|
O:
1.89%
H:
0.0%
C:
-0.64%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.73%
|
O:
0.07%
H:
0.0%
C:
0.0%
GSK
|
News
|
$43.7
0.02%
0.05%
|
|
Health Technology
|
5.33%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
3.87%
|
O:
0.74%
H:
0.52%
C:
-3.23%
GLAXF
|
News
|
$21.1
|
|
Health Technology
|
6.81%
|
O:
0.01%
H:
0.17%
C:
0.17%
ABBV
|
News
|
$153.14
0.53%
0.04%
|
|
Health Technology
|
12.24%
|
O:
1.05%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$104.5
|
|
Health Technology
|
12.02%
|
O:
-1.76%
H:
5.75%
C:
5.5%
JNJ
|
News
|
$182.12
-0.09%
0.1%
|
|
Health Technology
|
8.21%
|
O:
1.35%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.62
-1.5%
-0.41%
|
|
Health Technology
|
8.29%
|
O:
1.39%
H:
0.0%
C:
0.0%
AZN
|
News
|
$66.465
-0.65%
-0.42%
|
|
Health Technology
|
9.3%
|
O:
0.59%
H:
0.0%
C:
0.0%
therapy
market
Global Conjugated Monoclonal Antibodies (mAbs) Market Report 2022: A $12.09 Billion Market by 2026 - Forecast to 2031
Published:
2022-06-17
(Crawled : 13:20)
- prnewswire.com
ABBV
|
News
|
$153.14
0.53%
0.04%
|
|
Health Technology
|
12.24%
|
O:
1.05%
H:
0.0%
C:
0.0%
NVS
|
News
|
$85.28
0.53%
0.02%
|
|
Health Technology
|
4.73%
|
O:
0.07%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$84.01
|
|
Health Technology
|
3.87%
|
O:
0.74%
H:
0.52%
C:
-3.23%
report
market
← Previous
1
2
3
4
5
6
7
8
9
…
24
25
Next →
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ABBV
|
News
|
$153.14
0.53%
0.04%
|
|
Health Technology
APPN
|
News
4
|
$54.46
-1.05%
0.38%
|
|
Technology Services
APPS
|
News
|
$17.62
1.62%
5.48%
|
|
Technology Services
APYX
|
News
|
$6.04
1.51%
0.0%
|
|
Health Technology
BNPQF
|
News
|
$50.78
|
|
Finance
BNPQY
|
News
|
$25.46
|
|
Finance and Insurance
BNPZY
|
News
|
$
0%
|
|
Finance and Insurance
CNXC
|
News
|
$147.67
1.63%
-0.04%
|
|
Information
CNXCV
|
News
|
$2.27
0%
|
|
Commercial Services
DMYD
|
News
|
$16.21
0%
|
|
Finance
DMYT
|
News
|
$22.76
0%
|
|
Finance
DRE
|
News
|
$56.17
-2.23%
0.0%
|
|
Finance
EPZM
|
News
|
$1.47
54.09%
7.97%
|
|
Health Technology
ET
|
News
|
$10.14
0.4%
0.59%
|
|
Industrial Services
FBNC
|
News
|
$35.7
2.32%
0.0%
|
|
Finance
FBP
|
News
|
$13.52
0.67%
0.0%
|
|
Finance
FTRP
|
News
|
$0.81
1.25%
0.0%
|
|
Health Care and Social Assistan...
GRRB
|
News
|
$30.6
|
|
Finance and Insurance
HR
|
News
|
$27.23
1.38%
0.0%
|
|
Finance
HTA
|
News
|
$27.7
-0.22%
0.0%
|
|
Finance
IE
|
News
0 d
new
|
$
0%
|
|
n/a
IONQ
|
News
|
$4.83
-5.48%
2.07%
|
|
Professional, Scientific, and T...
LLY
|
News
4
|
$327.27
0.51%
0.04%
|
|
Health Technology
LMPX
|
News
|
$4.62
0.43%
0.0%
|
|
Technology Services
NFLX
|
News
|
$189.14
-0.9%
0.52%
|
|
Consumer Services
OBCI
|
News
|
$12.86
0.0%
|
|
Consumer Non-Durables
OMC
|
News
|
$64.75
0.23%
0.0%
|
|
Commercial Services
ONEW
|
News
|
$35.25
3.68%
0.0%
|
|
Retail Trade
OSCR
|
News
|
$4.55
2.94%
0.0%
|
|
PACB
|
News
|
$5.3
-5.53%
-1.78%
|
|
Health Technology
PEGA
|
News
|
$51.68
-1.97%
0.0%
|
|
Technology Services
PFHC
|
News
|
$19.75
6.35%
-4.95%
|
|
PLD
|
News
|
$120.21
-1.94%
0.54%
|
|
Finance
PSORF
|
News
|
$9.55
0%
|
|
Consumer Services
RDUS
|
News
|
$10.205
0.94%
-0.4%
|
|
Health Technology
SNY
|
News
|
$52.62
-1.5%
-0.41%
|
|
Health Technology
SNYNF
|
News
|
$104.5
|
|
Health Technology
SPRO
|
News
|
$0.931
-0.96%
3.19%
|
|
Health Technology
SREV
|
News
|
$1.45
-2.76%
|
|
Technology Services
TGTX
|
News
|
$4.34
-1.36%
-2.05%
|
|
Health Technology
TUP
|
News
4
|
$7.16
1.42%
0.0%
|
|
Producer Manufacturing
USAK
|
News
|
$30.85
-0.48%
-0.39%
|
|
Transportation
USWS
|
News
|
$0.995
4.08%
-0.63%
|
|
Finance
VRCA
|
News
|
$2.195
4.03%
10.43%
|
|
Health Technology
WWE
|
News
|
$61.0
0.63%
0.0%
|
|
Consumer Services
XRAY
|
News
|
$36.74
-0.05%
0.0%
|
|
Health Technology
ZEN
|
News
|
$74.65
0.65%
-0.07%
|
|
Technology Services